Amanote Research
Register
Sign In
Pcn144 - Cost-Effectiveness of Cabozantinib for Patients With Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.227
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
S. Kim
S. Han
H. Kim
H.S. Suh
Publisher
Elsevier BV